Financial Comparison
Sun Pharmaceutical Industries Limited vs Torrent Pharmaceuticals Limited
Click a ticker to view the full analysis.
In short
Sun Pharmaceutical Industries Limited is the more profitable of the two, keeping 19.7% of revenue as net profit against 15.7% for Torrent Pharmaceuticals Limited. Torrent Pharmaceuticals Limited trades at the higher trailing P/E (80.0× vs 38.8× for Sun Pharmaceutical Industries Limited), so investors pay more for each dollar of its earnings. Fisclear flags 0 medium- or high-severity risks for Sun Pharmaceutical Industries Limited and 2 for Torrent Pharmaceuticals Limited.
Based on filings for periods ending 31 Mar 2026 (SUNPHARMA.NS) and 31 Mar 2026 (TORNTPHARM.NS) · Updated
FisclearScore Comparison
FisclearScore is a quantitative model. SUNPHARMA.NS shown solid · TORNTPHARM.NS shown dashed. Not financial advice.
| Metric | SUNPHARMA.NS | TORNTPHARM.NS |
|---|---|---|
| Price | ₹1,773.40 | ₹4,738.50 |
| Market Cap | ₹4.25T | ₹1.80T |
| P/E (TTM) | 38.8x | 80.0x |
| P/B | 4.8x | 9.8x |
| Beta | 0.13 | 0.17 |
| Div Yield | 0.90% | 0.82% |
| Revenue (TTM) | ₹582.2B | ₹137.5B |
| Net Income | ₹114.8B | ₹21.6B |
| Gross Margin | 77.4% | 74.4% |
| Risk Flags | — | 2 flags |
Related comparisons
Data sourced from SEC EDGAR, Yahoo Finance, and official exchange filings. For informational purposes only. Not financial advice.